Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Ebling

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacy and Pharmacology|March 21, 1998
Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in ratsS Dutta, W F Ebling
Journal of Pharmaceutical Sciences|January 1, 1997
Parameter estimability of biphasic response modelsS Dutta, W F Ebling
Anesthesiology|January 7, 1998
Emulsion formulation reduces propofol's dose requirements and enhances safetyS Dutta, W F Ebling
Anesthesiology|September 22, 1998
Formulation-dependent brain and lung distribution kinetics of propofol in ratsS Dutta, W F Ebling
The Annals of Pharmacotherapy|January 1, 1996
Population pharmacodynamics: strategies for concentration-and effect-controlled clinical trialsW F Ebling, G Levy
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1986
The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbitsW F Ebling, W J Jusko
Journal of Pharmaceutical Sciences|February 1, 1996
Is it possible to estimate the parameters of the sigmoid Emax model with truncated data typical of clinical studies?S Dutta, Y Matsumoto, W F Ebling
Journal of Pharmaceutical Sciences|August 1, 1997
Propofol pharmacokinetics and pharmacodynamics assessed from a cremophor EL formulationS Dutta, Y Matsumoto, W F Ebling
Pharmaceutical Research|December 1, 1996
Feasibility of effect-controlled clinical trials of drugs with pharmacodynamic hysteresis using sparse dataW F Ebling, Y Matsumoto, G Levy
Clinical Pharmacology and Therapeutics|July 1, 1994
Concentration- or effect-controlled clinical trials with sparse dataG Levy, W F Ebling, A Forrest
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacy and Pharmacology|March 21, 1998
Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in ratsS Dutta, W F Ebling
Journal of Pharmaceutical Sciences|January 1, 1997
Parameter estimability of biphasic response modelsS Dutta, W F Ebling
Anesthesiology|January 7, 1998
Emulsion formulation reduces propofol's dose requirements and enhances safetyS Dutta, W F Ebling
Anesthesiology|September 22, 1998
Formulation-dependent brain and lung distribution kinetics of propofol in ratsS Dutta, W F Ebling
The Annals of Pharmacotherapy|January 1, 1996
Population pharmacodynamics: strategies for concentration-and effect-controlled clinical trialsW F Ebling, G Levy
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1986
The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbitsW F Ebling, W J Jusko
Journal of Pharmaceutical Sciences|February 1, 1996
Is it possible to estimate the parameters of the sigmoid Emax model with truncated data typical of clinical studies?S Dutta, Y Matsumoto, W F Ebling
Journal of Pharmaceutical Sciences|August 1, 1997
Propofol pharmacokinetics and pharmacodynamics assessed from a cremophor EL formulationS Dutta, Y Matsumoto, W F Ebling
Pharmaceutical Research|December 1, 1996
Feasibility of effect-controlled clinical trials of drugs with pharmacodynamic hysteresis using sparse dataW F Ebling, Y Matsumoto, G Levy
Clinical Pharmacology and Therapeutics|July 1, 1994
Concentration- or effect-controlled clinical trials with sparse dataG Levy, W F Ebling, A Forrest
Pageof 4